相关实验视频

Updated: Jun 16, 2025

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

Published on: February 21, 2015

综合转录组分析和lncRNA-miRNA-mRNA基于诱导的多能干细胞确定精神分裂症

Ningning Jia¹, Xuyuan Yin², Zhenhua Zhu²

¹Research Center of Biological Psychiatry, Suzhou Guangji Hospital, Suzhou Medical College of Soochow University, Suzhou 215137, China; Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.

Schizophrenia research

|May 1, 2025

概括

这项研究分析了精神分裂症患者的干细胞中的基因表达,确定了与症状相关的关键基因和调节网络. 这些发现为精神分裂症提供了潜在的生物标志物和治疗点.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

精神分裂症 (SCZ) 是一种复杂的疾病,分子机制不明.
识别关键的基因和生物网络对于理解SCZ病原体至关重要.

研究的目的:

研究SCZ患者和健康对照的诱导多能干细胞 (iPSC) 中的mRNA和非编码RNA表达的差异.
构建lncRNA-miRNA-mRNA调节网络并分析与临床表型的相关性.

主要方法:

来自5名SCZ患者和5名对照组的iPSCs的整体转录组测序.
对差异表达mRNAs (DE mRNAs),lncRNAs和miRNAs的分析.
构建lncRNA-miRNA-mRNA网络,并与SCZ症状进行相关性分析.

主要成果:

确定了139个DE mRNA,154个lncRNA和19个miRNA.
在诸如亡,炎症和KRAS信号传递等途径中发现了显著的丰富.
确定了十个与SCZ症状相关的枢纽基因 (例如ZEB1,GATA2),并建立了与临床表型相关的ceRNA网络.

结论:

该研究确定了潜在的枢纽基因,通路和监管网络,为SCZ分子机制提供了洞察力.
识别的枢纽基因和ceRNA与SCZ临床表型相关,表明潜在的生物标志物和治疗点.

关键词:

哈勃基因哈勃基因哈勃基因哈勃基因在 IPSC 里面,精神分裂症是一种精神分裂症.ceRNARNA是什么意思

更多相关视频

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Published on: November 26, 2018

相关概念视频

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Chromatin Modification in iPS Cells

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...